Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. Journal of Neurooncology. 2005

Cannabinoids and cancer. Mini-Reviews in Medicinal Chemistry. 2005

The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells. Gut. 2005

Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Research. 2005

Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. Journal of Pharmacology And Experimental Therapeutics. 2004

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Research. 2004

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro. BMJ Medicine. 2004

Cannabinoids: potential anticancer agents. Nature Reviews Cancer. 2003

Inhibition of tumor angiogenesis by cannabinoids. The FASEB Journal. 2003

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. Journal of Clinical Investigation. 2003

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature Medicine. 2000

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Letters. 1998

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proceedings of the National Academy of Sciences of the USA. 1998

Toxicology and Carcinogenesis Studies of 1 trans-delta-9-tetrahydrocannabinol in F344N/N Rats and BC63F1 Mice. National Institutes of Health National Toxicology Program, NIH Publication No. 97-3362. 1996.

Antineoplastic activity of cannabinoids. Journal of the National Cancer Institute. 1975